Effects of the Antiretroviral Raltegravir on Amyloid-Beta1-42-Induced Neuroinflammation 2310253
There is growing evidence supporting the potential role of microbial infections in the aetiology of Alzheimer’s disease (AD). We aim to evaluate the effect of raltegravir, either alone as a single therapy or combined with elacridar, a P-gp/BCRP inhibitor, on AD-related pathways in vitro. Flow cytometry com...